Specialty Pharma Journal Specialty, Precision & Technology
The SPJ Special Editions are a combination of a series of articles authored by industry experts and condensed into one publication on a particular disease state.
View the Latest SPJ Special Edition Publication on Hepatitis C
Breaking News
- FDA Approves ViiV Healthcare’s Rukobia, a First-in-Class Treatment for HIV in Adults with Few Treatment Options
- Phase 3 Trial of Kevzara in COVID-19 Patients Requiring Mechanical Ventilation Fails to Meet Primary and Secondary Endpoints
- CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
- MEI Pharma and Helsinn Group Discontinue Phase 3 Study of Pracinostat in AML After Interim Analysis
- Alexion Completes Acquisition of Portola Pharmaceuticals
- Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase as a Pre-Treatment Ahead of Gene Therapy in Select Indications
- Ipsen Joins Collaboration to Evaluate Cabozantinib Plus Atezolizumab in Metastatic NSCLC and Metastatic Castration-Resistant Prostate Cancer
- FDA Grants Fast Track Designation to MetVital’s Anhydrous Enol-Oxaloacetate for Glioblastoma Multiforme
- Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
- FDA Approves Bavencio as First-Line Maintenance Treatment for Locally Advanced or Metastatic Urothelial Carcinoma